Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology and Key Laboratory of Educational Ministry of China, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Department of Pharmacology, Institute of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin, China.
Mediators Inflamm. 2018 May 17;2018:9031452. doi: 10.1155/2018/9031452. eCollection 2018.
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is closely associated with airway inflammation including monocytes, lymphocytes, and neutrophils. Monocytes play an essential role in the pathogenesis of chronic obstructive pulmonary disease (COPD). To elucidate the association of circulating monocyte alteration with AECOPD, we analyzed monocyte subpopulation in the peripheral blood of 16 healthy volunteers and 22 AECOPD patients at the stages of admission and remission after clinical therapy. We found a dramatic increase of a previously unreported population of large size circulating atypical monocytes (A Mo) in AECOPD patients, characterized by higher forward scatter and lower side scatter values than the typical monocytes (T Mo) which were observed predominantly in healthy individuals. Further analysis showed that A Mo expressed higher levels of CD16, intercellular adhesion molecule 1 (ICAM-1), and chemotactic protein-1 receptor-2 (CCR2) than T Mo. In contrast, the expression of class II antigen (HLA-DR) by A Mo was lower than T Mo. More importantly, we observed that the percentage of circulating A Mo among total monocytes correlated with the length of hospital stay (time to remission) and disease duration. The data suggest that circulating A Mo might have the potential to serve as a biomarker in the diagnosis and prognosis of AECOPD.
慢性阻塞性肺疾病(COPD)急性加重(AECOPD)与气道炎症密切相关,包括单核细胞、淋巴细胞和中性粒细胞。单核细胞在 COPD 的发病机制中起重要作用。为了阐明循环单核细胞改变与 AECOPD 的关系,我们分析了 16 名健康志愿者和 22 名 AECOPD 患者在临床治疗后入院和缓解期的外周血单核细胞亚群。我们发现,AECOPD 患者中存在一种以前未报道的大尺寸循环非典型单核细胞(A Mo)的显著增加,其特征是前向散射较高,侧向散射较低,而典型单核细胞(T Mo)主要存在于健康个体中。进一步分析表明,A Mo 表达更高水平的 CD16、细胞间黏附分子 1(ICAM-1)和趋化蛋白-1 受体-2(CCR2),而 T Mo 表达更高水平的 CD16、细胞间黏附分子 1(ICAM-1)和趋化蛋白-1 受体-2(CCR2)。相反,A Mo 上 II 类抗原(HLA-DR)的表达低于 T Mo。更重要的是,我们观察到循环 A Mo 占总单核细胞的百分比与住院时间(缓解时间)和疾病持续时间相关。数据表明,循环 A Mo 可能有潜力作为 AECOPD 诊断和预后的生物标志物。